Suppr超能文献

具有脂肪肝和肝硬化疾病的肠道细菌的特征。

Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.

机构信息

Department of Gastroenterology, the Affiliated hospital of Qingdao University, Qingdao, Shandong Province, PR China.

Department of Gastroenterology, the Affiliated hospital of Qingdao University, Qingdao, Shandong Province, PR China.

出版信息

Ann Hepatol. 2019 Nov-Dec;18(6):796-803. doi: 10.1016/j.aohep.2019.06.020. Epub 2019 Sep 13.

Abstract

Non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) are significant health burdens worldwide with a substantial rise in prevalence. Both can progress to liver cirrhosis. Recent studies have shown that the gut microbiome was associated with NAFLD/AFLD development and progression. The present review focuses on the characteristics of bacteria in NAFLD, AFLD and liver cirrhosis. The similarities and differences of intestinal bacteria are discussed. This study reviews the existing literatures on the microbiota, fatty liver disease, and liver cirrhosis based on Pubmed database. The study showed NAFLD was characterized by increased amounts of Lachnospiraceae from the phylum Firmicutes and Roseburia from the Lachnospiraceae family, and the proportion of Enterobacteria and Proteobacteria was increased after alcohol intake. Reduced Bacteroidetes was observed in cirrhosis. Microbiota can improve or aggravate the above liver diseases through several mechanisms, like increasing liver lipid metabolism, increasing alcohol production, increasing intestinal permeability, bacterial translocation, intestinal bacterial overgrowth, enteric dysbiosis, and impairing bile secretion. Different hepatic diseases owned different intestinal bacterial characters. Microbiota can improve or aggravate three kinds of liver diseases through several mechanisms. However, the depletion of these bacteria is needed to verify their role in liver disease.

摘要

非酒精性脂肪性肝病 (NAFLD) 和酒精性脂肪性肝病 (AFLD) 是全球范围内的重大健康负担,其患病率显著上升。两者都可进展为肝硬化。最近的研究表明,肠道微生物群与 NAFLD/AFLD 的发生和发展有关。本综述重点介绍了 NAFLD、AFLD 和肝硬化中细菌的特征。讨论了肠道细菌的异同。本研究基于 Pubmed 数据库综述了关于微生物群、脂肪性肝病和肝硬化的现有文献。研究表明,NAFLD 的特征是厚壁菌门的lachnospiraceae 增多和lachnospiraceae 科的 roseburia 增多,饮酒后肠杆菌科和变形菌科的比例增加。肝硬化时观察到拟杆菌门减少。微生物群可以通过多种机制改善或加重上述肝脏疾病,如增加肝脏脂质代谢、增加酒精生成、增加肠道通透性、细菌易位、肠道细菌过度生长、肠道菌群失调和损害胆汁分泌。不同的肝脏疾病具有不同的肠道细菌特征。微生物群可以通过多种机制改善或加重三种肝脏疾病,但需要消除这些细菌以验证它们在肝脏疾病中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验